[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:bladder-carcinoma:programmed-cell-death-1-ligand-1":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Bladder Carcinoma","Programmed Cell Death 1 Ligand 1",3,[8,16,23],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05533697","Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:19:04.543908Z","2026-05-05T02:43:29.371442Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT04235777","Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies",[20],"Phase 1","2026-08-03T03:29:32.085476Z","2026-05-05T02:43:29.189537Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07646847","A Study of a Side Effects and Resource Navigation Program for People With Cancer",[],"2026-08-26T02:18:45.196599Z","2026-07-30T01:46:14.435535Z"]